Skip to content

Effect Of Dexmedetomidine Nasal Spray On Recovery After Septoplasty

Effect Of Dexmedetomidine Nasal Spray On Recovery After Septoplasty

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073335
Enrollment
Unknown
Registered
2023-07-07
Start date
2023-07-10
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septal deviation

Interventions

Dexmedetomidine Group:Perform 1 ug/kg dexmedetomidine nasal drops before anesthesia induction
Saline group:Nasal saline drops are performed prior to induction of anesthesia

Sponsors

Beijing Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Gender is not limited, ages 18-65 years, ASA graded I-II. Sign an informed consent form with the patient before surgery.

Exclusion criteria

Exclusion criteria: history of serious adverse effects; Patients with hypersensitivity to dexmedetomidine or anesthetic drugs; Hypotension and bradycardia; BMI>35kg/m2 ; history of cardiac disease such as ischemic heart disease; asthma, sleep apnea, pregnancy; use of a-2 agonists or antagonists; History of opioid or sedative use in the week prior to surgery.

Design outcomes

Primary

MeasureTime frame
QoR-15 postoperative recovery quality score;

Secondary

MeasureTime frame
Postoperative 1hVAS score;The length of time the patient stays within the PACU;Postoperative adverse effects;Patient satisfaction score;Perioperative opioid dosage;The patient's tolerance to nasal tamponade;

Countries

China

Contacts

Public ContactFushan Xue

Beijing Friendship Hospital

xyefushan@aliyun.com+86 139 1117 7655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026